N-(tert-Butoxycarbonyl)sulfamide

We are N-(tert-Butoxycarbonyl)sulfamide CAS:148017-28-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:N-(tert-Butoxycarbonyl)sulfamide
CAS.NO:148017-28-1
Synonyms:N-(tert-Butoxycarbonyl)sulfamide
tert-Butyl-sulfamoylcarbamat
2-Methyl-2-propanyl sulfamoylcarbamate
tert-Butyl sulfamoylcarbamate
tert-butyl N-sulfamoylcarbamate
Carbamic acid, N-(aminosulfonyl)-, 1,1-dimethylethyl ester
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Molecular Formula C5H12N2O4S
Molecular Weight 196.225
 
Specification:
Appearance:white to light yellow crystal powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Doripenem(CAS:148016-81-3).

N-(tert-Butoxycarbonyl)sulfamide


Related News: In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC.1,6-Dibromohexane CAS:629-03-8 In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC.100-00-5 In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC.Ethoxydimethylvinylsilane CAS:5356-83-2 Due to the cyclic nature of the upstream chemical products of the API, it is expected that the impact of price fluctuations of raw materials on the performance of API companies is unavoidable, but companies with thick product lines and the ability to produce intermediates are expected to minimize the upstream price impact.Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday.

Related Products
Product Name
(2R)-Methyl 2-acetamido-3-chloro-3-hydroxypropanoate View Details
2-Bromo-3-Fluoro-6-Picoline View Details
N-(biphenyl-4-yl)-3-carbazoleboronic acid View Details
(R,E)-ethyl 5-([1,1′-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoate manufacturer 1,4-difluorobenzene manufacturer 6-Cyano-2-[1-(4-ethyl-3-iodophenyl)-1-methylethyl]-1H-indole-3-carboxylic acid 1,1-dimethylethyl ester manufacturer 2-(chloromethyl)-2-(4-chlorophenyl)hexanenitrile manufacturer [(1S,4R)-4-aminocyclopent-2-en-1-yl]methanol,(2S,3S)-2,3-dihydroxybutanedioic acid manufacturer